A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Gastric Cancer

Topics

Medicine

Cancer Oncology

Pathology

Internal Medicine

Surgery

Show all topics

DOI

10.1007/s10120-019-01034-7

License

CC-BY

Other Formats

PDF